カテゴリー： QYResearch, 世界

気管支拡張薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Bronchiectasis Drugs Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18244）・商品コード：DATA909X18244
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、気管支拡張薬の世界市場について調査・分析し、気管支拡張薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗生物質、去痰薬、その他の薬物）、用途別（病院、研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の気管支拡張薬市場動向
・主要企業別マーケットシェア
・気管支拡張薬の種類別市場規模2014-2019
（抗生物質、去痰薬、その他の薬物）
・気管支拡張薬の用途別市場規模2014-2019
（病院、研究所、クリニック、その他）
・気管支拡張薬の北米市場：主要企業・種類別/用途別市場規模
・気管支拡張薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・気管支拡張薬の中国市場：主要企業・種類別/用途別市場規模
・気管支拡張薬の日本国内市場：主要企業・種類別/用途別市場規模
・気管支拡張薬の東南アジア市場：主要企業・種類別/用途別市場規模
・気管支拡張薬のインド市場：主要企業・種類別/用途別市場規模
・気管支拡張薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Endo International Plc、GlaxoSmithKline Plc、Neopharma LLC、Pfizer Inc.、Reckitt Benckiser Group Plc）
・気管支拡張薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently. The use of this probe will also help in identifying the exact causing agent of bronchiectasis. The high-resolution computed tomography (HRCT) scan has also emerged as a popular diagnostic technique for screening bronchiectasis and other respiratory diseases. Such advances in the diagnostics of respiratory diseases will enable pulmonologists and otolaryngologists to precisely identify the stage of the disease and provide appropriate and timely treatment to patients.
In 2018, the global Bronchiectasis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Bronchiectasis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bronchiectasis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Endo International Plc
GlaxoSmithKline Plc
Neopharma LLC
Pfizer Inc.
Reckitt Benckiser Group Plc
…

Market segment by Type, the product can be split into
Antibiotics
Expectorants
Other drugs

Market segment by Application, split into
Hospital
Research institute
Clinic
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Bronchiectasis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Bronchiectasis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Bronchiectasis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibiotics
1.4.3 Expectorants
1.4.4 Other drugs
1.5 Market by Application
1.5.1 Global Bronchiectasis Drugs Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Research institute
1.5.4 Clinic
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Bronchiectasis Drugs Market Size
2.2 Bronchiectasis Drugs Growth Trends by Regions
2.2.1 Bronchiectasis Drugs Market Size by Regions (2019-2025)
2.2.2 Bronchiectasis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Bronchiectasis Drugs Market Size by by Players
3.1.1 Global Bronchiectasis Drugs Revenue by by Players (2014-2019)
3.1.2 Global Bronchiectasis Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Bronchiectasis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Bronchiectasis Drugs Key Players Head office and Area Served
3.3 Key Players Bronchiectasis Drugs Product/Solution/Service
3.4 Date of Enter into Bronchiectasis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Bronchiectasis Drugs Market Size by Type (2014-2019)
4.2 Global Bronchiectasis Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Bronchiectasis Drugs Market Size (2014-2019)
5.2 Bronchiectasis Drugs Key Players in North America
5.3 North America Bronchiectasis Drugs Market Size by Type
5.4 North America Bronchiectasis Drugs Market Size by Application

6 Europe
6.1 Europe Bronchiectasis Drugs Market Size (2014-2019)
6.2 Bronchiectasis Drugs Key Players in Europe
6.3 Europe Bronchiectasis Drugs Market Size by Type
6.4 Europe Bronchiectasis Drugs Market Size by Application

7 China
7.1 China Bronchiectasis Drugs Market Size (2014-2019)
7.2 Bronchiectasis Drugs Key Players in China
7.3 China Bronchiectasis Drugs Market Size by Type
7.4 China Bronchiectasis Drugs Market Size by Application

8 Japan
8.1 Japan Bronchiectasis Drugs Market Size (2014-2019)
8.2 Bronchiectasis Drugs Key Players in Japan
8.3 Japan Bronchiectasis Drugs Market Size by Type
8.4 Japan Bronchiectasis Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Bronchiectasis Drugs Market Size (2014-2019)
9.2 Bronchiectasis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Bronchiectasis Drugs Market Size by Type
9.4 Southeast Asia Bronchiectasis Drugs Market Size by Application

10 India
10.1 India Bronchiectasis Drugs Market Size (2014-2019)
10.2 Bronchiectasis Drugs Key Players in India
10.3 India Bronchiectasis Drugs Market Size by Type
10.4 India Bronchiectasis Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Bronchiectasis Drugs Market Size (2014-2019)
11.2 Bronchiectasis Drugs Key Players in Central & South America
11.3 Central & South America Bronchiectasis Drugs Market Size by Type
11.4 Central & South America Bronchiectasis Drugs Market Size by Application

12 International Players Profiles
12.1 Endo International Plc
12.1.1 Endo International Plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bronchiectasis Drugs Introduction
12.1.4 Endo International Plc Revenue in Bronchiectasis Drugs Business (2014-2019))
12.1.5 Endo International Plc Recent Development
12.2 GlaxoSmithKline Plc
12.2.1 GlaxoSmithKline Plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bronchiectasis Drugs Introduction
12.2.4 GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Plc Recent Development
12.3 Neopharma LLC
12.3.1 Neopharma LLC Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bronchiectasis Drugs Introduction
12.3.4 Neopharma LLC Revenue in Bronchiectasis Drugs Business (2014-2019)
12.3.5 Neopharma LLC Recent Development
12.4 Pfizer Inc.
12.4.1 Pfizer Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bronchiectasis Drugs Introduction
12.4.4 Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2014-2019)
12.4.5 Pfizer Inc. Recent Development
12.5 Reckitt Benckiser Group Plc
12.5.1 Reckitt Benckiser Group Plc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bronchiectasis Drugs Introduction
12.5.4 Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2014-2019)
12.5.5 Reckitt Benckiser Group Plc Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Bronchiectasis Drugs Key Market Segments
Table Key Players Bronchiectasis Drugs Covered
Table Global Bronchiectasis Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Antibiotics Figures
Table Key Players of Antibiotics
Figuer Expectorants Figures
Table Key Players of Expectorants
Figuer Other drugs Figures
Table Key Players of Other drugs
Table Global Bronchiectasis Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Bronchiectasis Drugs Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Research institute Case Studies
Figure Clinic Case Studies
Figure Other Case Studies
Figure Bronchiectasis Drugs Report Years Considered
Figure Global Bronchiectasis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bronchiectasis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Bronchiectasis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Bronchiectasis Drugs Market Share by Regions 2014-2019
Figure Global Bronchiectasis Drugs Market Share by Regions 2014-2019
Figure Global Bronchiectasis Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Bronchiectasis Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Bronchiectasis Drugs Market Share by by Players (2014-2019)
Figure Global Bronchiectasis Drugs Market Share by by Players in 2018
Table Global Bronchiectasis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bronchiectasis Drugs Product/Solution/Service
Table Date of Enter into Bronchiectasis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bronchiectasis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Bronchiectasis Drugs Market Size Share by Type (2014-2019)
Figure Global Bronchiectasis Drugs Market Size Market Share by Type (2014-2019)
Table Global Bronchiectasis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Bronchiectasis Drugs Market Size Share by Application (2014-2019)
Figure Global Bronchiectasis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Bronchiectasis Drugs Revenue Market Share by Application in 2018
Figure North America Bronchiectasis Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Bronchiectasis Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Bronchiectasis Drugs Market Share (2018-2019)
Table North America Bronchiectasis Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Bronchiectasis Drugs Market Share by Type 2014-2019
Table North America Bronchiectasis Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Bronchiectasis Drugs Market Share by Application 2014-2019
Figure Europe Bronchiectasis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Bronchiectasis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Bronchiectasis Drugs Market Share (2018-2019)
Table Europe Bronchiectasis Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Bronchiectasis Drugs Market Share by Type 2014-2019
Table Europe Bronchiectasis Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Bronchiectasis Drugs Market Share by Application 2014-2019
Figure China Bronchiectasis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Bronchiectasis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Bronchiectasis Drugs Market Share (2018-2019)
Table China Bronchiectasis Drugs Market Size by Type 2014-2019 (Million US$)
Table China Bronchiectasis Drugs Market Share by Type 2014-2019
Table China Bronchiectasis Drugs Market Size by Application 2014-2019 (Million US$)
Table China Bronchiectasis Drugs Market Share by Application 2014-2019
Figure Japan Bronchiectasis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Bronchiectasis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Bronchiectasis Drugs Market Share (2018-2019)
Table Japan Bronchiectasis Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Bronchiectasis Drugs Market Share by Type 2014-2019
Table Japan Bronchiectasis Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Bronchiectasis Drugs Market Share by Application 2014-2019
Figure Southeast Asia Bronchiectasis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bronchiectasis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bronchiectasis Drugs Market Share (2018-2019)
Table Southeast Asia Bronchiectasis Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Bronchiectasis Drugs Market Share by Type 2014-2019
Table Southeast Asia Bronchiectasis Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Bronchiectasis Drugs Market Share by Application 2014-2019
Figure India Bronchiectasis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Bronchiectasis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Bronchiectasis Drugs Market Share (2018-2019)
Table India Bronchiectasis Drugs Market Size by Type 2014-2019 (Million US$)
Table India Bronchiectasis Drugs Market Share by Type 2014-2019
Table India Bronchiectasis Drugs Market Size by Application 2014-2019 (Million US$)
Table India Bronchiectasis Drugs Market Share by Application 2014-2019
Figure Central & South America Bronchiectasis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bronchiectasis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bronchiectasis Drugs Market Share (2018-2019)
Table Central & South America Bronchiectasis Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Bronchiectasis Drugs Market Share by Type 2014-2019
Table Central & South America Bronchiectasis Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Bronchiectasis Drugs Market Share by Application 2014-2019
Table Endo International Plc Company Details
Table Endo International Plc Revenue in Bronchiectasis Drugs Business 2014-2019 (Million US$)
Figure Endo International Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2014-2019)
Table Endo International Plc Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2014-2019)
Table GlaxoSmithKline Plc Recent Development
Table Neopharma LLC Company Details
Table Neopharma LLC Revenue in Bronchiectasis Drugs Business 2014-2019 (Million US$)
Figure Neopharma LLC Revenue Growth Rate in Bronchiectasis Drugs Business (2014-2019)
Table Neopharma LLC Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Bronchiectasis Drugs Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Bronchiectasis Drugs Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Reckitt Benckiser Group Plc Company Details
Table Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business 2014-2019 (Million US$)
Figure Reckitt Benckiser Group Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2014-2019)
Table Reckitt Benckiser Group Plc Recent Development
Table Global Bronchiectasis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Bronchiectasis Drugs Market Size Share by Regions (2019-2025)
Figure Global Bronchiectasis Drugs Market Size Share by Regions in 2025
Figure North America Bronchiectasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bronchiectasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Bronchiectasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bronchiectasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bronchiectasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Bronchiectasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bronchiectasis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Bronchiectasis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Bronchiectasis Drugs Market Size by Product (2019-2025)
Figure Global Bronchiectasis Drugs Market Size by Product in 2025
Table Global Bronchiectasis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Bronchiectasis Drugs Market Size by Application (2019-2025)
Figure Global Bronchiectasis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Endo International Plc、GlaxoSmithKline Plc、Neopharma LLC、Pfizer Inc.、Reckitt Benckiser Group Plc

★調査レポート[気管支拡張薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18244)販売に関する免責事項を必ずご確認ください。
★調査レポート[気管支拡張薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • そう痒治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18875 / QYResearch / 2019年11月25日 / ※当調査レポートでは、そう痒治療薬の世界市場について調査・分析し、そう痒治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（局所、経口、非経口）、用途別（血液性そう痒症、腫瘍性そう痒症、腎そう痒症、内分泌性掻そう痒症、胆汁うっ滞性そう痒症）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のそう痒治療薬市場動向 ・主要企業別マーケットシェア ・そう痒治療薬の種類別市場規模2014-2019 （局所、経口、非経口） ・そう痒治療薬の用途別市場規模2014-2019 （血液性そう痒症、腫瘍性そう痒症、腎そう痒症、内分泌性掻そう痒症、胆汁うっ滞性そう痒症） ・そう痒治療薬の北米市場：主要企業・種類別/用途別市場規模 ・そう痒治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs.The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other forms of drug delivery methods. Moreover, transdermal drug delivery systems increase the bioavailability of active ingredients and prevent destructive hepatic first-pass metabolism. However, the delivery of small and lipophilic drugs is difficult through the method of drug development. In 2018, the global Pruritus Drugs market size was xx million US$ and it is expected to...
  • 起立性低血圧治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18788 / QYResearch / 2019年11月25日 / ※当調査レポートでは、起立性低血圧治療薬の世界市場について調査・分析し、起立性低血圧治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物）、用途別（病院、医学研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の起立性低血圧治療薬市場動向 ・主要企業別マーケットシェア ・起立性低血圧治療薬の種類別市場規模2014-2019 （ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物） ・起立性低血圧治療薬の用途別市場規模2014-2019 （病院、医学研究所、クリニック、その他） ・起立性低血圧治療薬の北米市場：主要企業・種類別/用途別市場規模 ・起立性低血圧治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.Orthostatic hypotension is difficult to treat with single-drug therapy because orthostatic stress varies as per the circumstances during the day. Moreover, most of the OH drugs are used to improve postural symptoms, standing time, and function instead of achieving upright normotension that may cause supine hypertension. These factors have boosted the use of a combination of various drugs, such as midodrine and fludrocortisone, midodrine and pyridostigmine, or midodrine and octreotide, for the...
  • クリプトコッカス薬の世界市場：規模・現状・予測2019-2025
    DATA909X18352 / QYResearch / 2019年11月25日 / ※当調査レポートでは、クリプトコッカス薬の世界市場について調査・分析し、クリプトコッカス薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アムホテリシンB、フルシトシン、フルコナゾール、その他）、用途別（病院薬局、小売薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のクリプトコッカス薬市場動向 ・主要企業別マーケットシェア ・クリプトコッカス薬の種類別市場規模2014-2019 （アムホテリシンB、フルシトシン、フルコナゾール、その他） ・クリプトコッカス薬の用途別市場規模2014-2019 （病院薬局、小売薬局、その他） ・クリプトコッカス薬の北米市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, called meningitis.Symptoms of the disease include - fever, headache, fatigue, dry cough and blurred vision.It can be treated by dozing off with amphotericin B, fluorocytosine and fluconazole.In 2018, the global Cryptococcosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR...
  • 食道癌治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18452 / QYResearch / 2019年11月25日 / ※当調査レポートでは、食道癌治療薬の世界市場について調査・分析し、食道癌治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他）、用途別（標的療法、化学療法）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の食道癌治療薬市場動向 ・主要企業別マーケットシェア ・食道癌治療薬の種類別市場規模2014-2019 （フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他） ・食道癌治療薬の用途別市場規模2014-2019 （標的療法、化学療法） ・食道癌治療薬の北米市場：主要企業・種類別/用途別市場規模 ・食道癌治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing up or vomiting blood.Various combinations of drugs such as fluorouracil, cisplatin, docetaxel, and carboplatin are involved in standard chemotherapy regimens for the treatment of esophageal cancer. These drugs are selected based on adverse drug reactions and cancer subtypes. To ensure patient access to available therapeutics, governments in developed countries are introducing reimbursement...
  • 免疫性血小板減少薬の世界市場：規模・現状・予測2019-2025
    DATA909X18558 / QYResearch / 2019年11月25日 / ※当調査レポートでは、免疫性血小板減少薬の世界市場について調査・分析し、免疫性血小板減少薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物）、用途別（バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の免疫性血小板減少薬市場動向 ・主要企業別マーケットシェア ・免疫性血小板減少薬の種類別市場規模2014-2019 （トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物） ・免疫性血小板減少薬の用途別市場規模2014-2019 （バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関） ・免疫性血小板減少薬の北米市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.End-users prefer biosimilars over biologics because of their low cost. The low cost of biosimilars can be attributed to the fewer number of clinical trials required for approval. The upcoming expiration of patents in the immune thrombocytopenia drugs market will fuel the development of biosimilars for those products. For instance, the forthcoming expiration of patents of Nplate (romiplostim) and rituximab has encouraged market vendors to develop their biosimilars. This will also create several opportunities for new vendors to enter the market. Hence, the...
  • 鼻ポリープ薬の世界市場：規模・現状・予測2019-2025
    DATA909X18738 / QYResearch / 2019年11月25日 / ※当調査レポートでは、鼻ポリープ薬の世界市場について調査・分析し、鼻ポリープ薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の鼻ポリープ薬市場動向 ・主要企業別マーケットシェア ・鼻ポリープ薬の種類別市場規模2014-2019 （コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他） ・鼻ポリープ薬の用途別市場規模2014-2019 （病院、クリニック、その他） ・鼻ポリープ薬の北米市場：主要企業・種類別/用途別市場規模 ・鼻ポリープ薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose.In 2018, the global Nasal Polyps Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on...
  • 強迫性障害治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18761 / QYResearch / 2019年11月25日 / ※当調査レポートでは、強迫性障害治療薬の世界市場について調査・分析し、強迫性障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（SSRI、TCA、その他）、用途別（病院、クリニック、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の強迫性障害治療薬市場動向 ・主要企業別マーケットシェア ・強迫性障害治療薬の種類別市場規模2014-2019 （SSRI、TCA、その他） ・強迫性障害治療薬の用途別市場規模2014-2019 （病院、クリニック、研究所、その他） ・強迫性障害治療薬の北米市場：主要企業・種類別/用途別市場規模 ・強迫性障害治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive disorder drugs market growth. Conventional therapies used to treat the condition are only short-term treatment. The conventional anti-anxiety, antipsychotic, and antidepressant drugs are administered along with behavioral therapies and psychotherapy. The current long-term treatment involves the management of the condition, which requires patient compliance that has its drawbacks. Vendors are leveraging this situation and are focusing on the R&D...
  • 体部白癬用薬の世界市場：規模・現状・予測2019-2025
    DATA909X19035 / QYResearch / 2019年11月25日 / ※当調査レポートでは、体部白癬用薬の世界市場について調査・分析し、体部白癬用薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗真菌剤、ステロイド、抗感染性組み合わせ）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の体部白癬用薬市場動向 ・主要企業別マーケットシェア ・体部白癬用薬の種類別市場規模2014-2019 （抗真菌剤、ステロイド、抗感染性組み合わせ） ・体部白癬用薬の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・体部白癬用薬の北米市場：主要企業・種類別/用途別市場規模 ・体部白癬用薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.In 2018, the global Tinea Corporis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Tinea Corporis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tinea Corporis Drugs development in North America,...

    • ◆H&Iグローバルリサーチのお客様（例）◆